DIVIS LABORATORIES
Back to Balance Sheet
|
DIVIS LABORATORIES Last 5 Year Long Term Provisions History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Long Term Provisions | - | ₹37 Cr | ₹31 Cr | ₹27 Cr | ₹25 Cr |
What is the latest Long Term Provisions ratio of DIVIS LABORATORIES ?
| Year | Long Term Provisions |
|---|---|
| Mar2025 | - |
| Mar2024 | ₹37 Cr |
| Mar2023 | ₹31 Cr |
| Mar2022 | ₹27 Cr |
| Mar2021 | ₹25 Cr |
How is Long Term Provisions of DIVIS LABORATORIES Trending?
| Years | Long Term Provisions | % Change | |
|---|---|---|---|
| Mar2025 | - | -100.00 | |
| Mar2024 | ₹37 Cr | 19.35 | |
| Mar2023 | ₹31 Cr | 16.06 | |
| Mar2022 | ₹27 Cr | 5.07 | |
| Mar2021 | ₹25 Cr | - | |
Compare Long Term Provisions of peers of DIVIS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DIVIS LABORATORIES | ₹175,677.4 Cr | 4% | 5.2% | 11.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹415,073.0 Cr | -0% | -3.2% | -5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹134,121.0 Cr | 3.6% | 7% | 22% | Stock Analytics | |
| CIPLA | ₹118,431.0 Cr | -3.5% | -1.5% | -2.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,944.0 Cr | -3.2% | -3.3% | -10.6% | Stock Analytics | |
| MANKIND PHARMA | ₹90,806.8 Cr | 0.3% | 2.4% | -22.7% | Stock Analytics | |
DIVIS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DIVIS LABORATORIES | 4% |
5.2% |
11.9% |
| SENSEX | -2.6% |
-1.3% |
7.2% |
You may also like the below Video Courses